|
CYTOCHROME P450 INHIBITORS MAY INHIBIT 25 HYDROXYLATION OF DOXERCALCIFEROL, HENCE FORMATION OF ACTIVE MOITY MAY BE HINDERED
|
DAPOXETINE DOSE IS RESTRICTED TO 30 MG DUE TO POSSIBILITY OF INCREASED SIDE EFFECTS ON COADMINISTRATION
|
HIGH LEVELS OF HMG-COA REDUCTASE INHIBITORY ACTIVITY IN PLASMA;LOVASTATIN IS METABOLIZED BY CYP3A4 ISOENZYME,CERTAIN AGENTS, SHARE THIS METABOLIC PATHWAY AND CAN RAISE THE PLASMA LEVELS OF LOVASTATIN & MAY INCREASE THE RISK OF MYOPATHY
|
HIGH LEVELS OF HMG-COA REDUCTASE INHIBITORY ACTIVITY IN PLASMA;LOVASTATIN IS METABOLIZED BY CYP3A4 ISOENZYME,CERTAIN AGENTS, SHARE THIS METABOLIC PATHWAY AND CAN RAISE THE PLASMA LEVELS OF LOVASTATIN & MAY INCREASE THE RISK OF MYOPATHY
|
HIGH LEVELS OF HMG-COA REDUCTASE INHIBITORY ACTIVITY IN PLASMA;LOVASTATIN IS METABOLIZED BY CYP3A4 ISOENZYME,CERTAIN AGENTS, SHARE THIS METABOLIC PATHWAY AND CAN RAISE THE PLASMA LEVELS OF LOVASTATIN & MAY INCREASE THE RISK OF MYOPATHY
|
HIGH LEVELS OF HMG-COA REDUCTASE INHIBITORY ACTIVITY IN PLASMA;LOVASTATIN IS METABOLIZED BY CYP3A4 ISOENZYME,CERTAIN AGENTS, SHARE THIS METABOLIC PATHWAY AND CAN RAISE THE PLASMA LEVELS OF LOVASTATIN & MAY INCREASE THE RISK OF MYOPATHY
|
OXICONAZOLE CAN INHIBIT ITS METABOLISM THERE BY INCREASING SERUM LEVELS
|
OXICONAZOLE CAN INHIBIT ITS METABOLISM THERE BY INCREASING SERUM LEVELS
|
OXICONAZOLE CAN INHIBIT ITS METABOLISM THERE BY INCREASING SERUM LEVELS
|
OXICONAZOLE CAN INHIBIT ITS METABOLISM THERE BY INCREASING SERUM LEVELS
|
OXICONAZOLE CAN INHIBIT ITS METABOLISM THERE BY INCREASING SERUM LEVELS
|
OXICONAZOLE CAN INHIBIT ITS METABOLISM THERE BY INCREASING SERUM LEVELS
|
OXICONAZOLE CAN INHIBIT ITS METABOLISM THERE BY INCREASING SERUM LEVELS
|
OXICONAZOLE CAN INHIBIT ITS METABOLISM THERE BY INCREASING SERUM LEVELS
|
OXICONAZOLE CAN INHIBIT ITS METABOLISM THERE BY INCREASING SERUM LEVELS
|
OXICONAZOLE CAN INHIBIT ITS METABOLISM THERE BY INCREASING SERUM LEVELS
|
OXICONAZOLE CAN INHIBIT ITS METABOLISM THERE BY INCREASING SERUM LEVELS
|
CO-ADMINISTRATION CAN INCREASE PLASMA LEVELS OF CICLESONIDE LEADING TO INCREASED CHANCES OF CUSHING SYNDROME
|